Neurocrine Biosciences Inc (NBIX)

NASDAQ
95.20
-3.10(-3.15%)
After Hours
95.20
0.00(0.00%)
- Real-time Data
  • Volume:
    1,062,686
  • Day's Range:
    94.95 - 98.95
  • 52 wk Range:
    71.88 - 108.01

NBIX Overview

Prev. Close
98.3
Day's Range
94.95-98.95
Revenue
1.21B
Open
97.61
52 wk Range
71.88-108.01
EPS
0.73
Volume
1,062,686
Market Cap
9.1B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
759,677
P/E Ratio
134.89
Beta
0.64
1-Year Change
-2.31%
Shares Outstanding
95,576,662
Next Earnings Date
01 Aug 2022
What is your sentiment on Neurocrine?
or
Market is currently closed. Voting is open during market hours.

Neurocrine Biosciences Inc News

Neurocrine Biosciences Inc Company Profile

Neurocrine Biosciences Inc Company Profile

Employees
900

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering, developing and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids. Its product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 milligram (mg), 60 mg and 80 mg capsules); ONGENTYS (opicapone) is an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease; ORILISSA (elagolix) is used for the management of moderate to severe endometriosis pain in women, and ORIAHNN (elagolix, estradiol, and norethindrone acetate and elagolix capsules) is a non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in women.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellNeutralStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellStrong SellNeutralStrong Buy
  • 2020.08.26 @ $116
    0
    • 24/7. 2021Mar. $88. BOA Tgt $128
      0